Navigation Links
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients

- The safety and efficacy of PROCRIT therapy have not been established in

patients with a known history of a seizure disorder or underlying

hematologic disease (eg, sickle cell anemia, myelodysplastic syndromes,

or hypercoagulable disorders).

-- In some female patients, menses have resumed following PROCRIT therapy;

the possibility of pregnancy should be discussed and the need for

contraception evaluated.

-- Prior to and regularly during PROCRIT therapy monitor iron status;

transferrin saturation should be greater than or equal to 20% and

ferritin should be greater than or equal to 100 ng/mL. During therapy

absolute or functional iron deficiency may develop and all patients

will eventually require supplemental iron to adequately support

erythropoiesis stimulated by PROCRIT.

-- In studies, the most common side effects included fever (pyrexia),

diarrhea, nausea, vomiting, swelling of hands or feet (edema), lack or

loss of strength or weakness (asthenia, fatigue), shortness of breath,

high blood pressure, headache, joint pain (arthralgias), abnormal skin

sensations (as tingling or tickling or itching or burning;

paresthesia), rash, constipation, and upper respiratory infection.

Please visit for the full Prescribing Information, including the Boxed Warning.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients' health. Located in Bridgewater, N.J., Ortho Biote

SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer
2. Phillips Plastics to help develop orthopedics with stem cells
3. The state of global biotech: An Ernst & Young perspective
4. Olympics of biotechnology has international flavor
5. Biotech officials praise focus of new venture fund
6. Getting noticed in Genetown: Wisconsin biotech on display
7. Madison biotech NimbleGen files for IPO; one of states best-funded firms
8. Wisconsin biotech firm receives $107K NIH grant
9. Biotech executive books a career flight thats closer to home
10. Manufacturing partnership will move into biotech and biomedical spaces
11. Wisconsin wont get Georgia biotech without a fight
Post Your Comments:
(Date:6/3/2015)... Research and Markets ( ... "2015 Strategies in the US Immunoprotein ... offering. This new 236-page report ... market, including emerging tests, technologies, instrumentation, sales ... leading suppliers. During the next ...
(Date:6/3/2015)... BASEL, Switzerland , June 3, 2015 ... Research & Treatment of Cancer (EORTC), European Association of ... congress in Istanbul demonstrate that ... of methyltransferase (MGMT) status and in combination with radiotherapy ... EDO-S101 is a first in class fusion molecule that ...
(Date:6/3/2015)... CA (PRWEB) June 03, 2015 On April ... Senate Energy, Utilities and Communications Committee (11-0) and indicates the ... CAP) and renewable energy. , The Committee Chairman supports the ... increase the CAP by 8,000 GWh and would also like ... wait list. , This “Wait List” and timing are ...
(Date:6/3/2015)... June 03, 2015 Typical racks for ... preconfigured heights and depths often taking up unnecessary room ... Modular Ultra Low 5 Box Freezer Racks offer ... with existing freezer storage boxes and freezers. , ... for multiple experiments or multiple people because users can ...
Breaking Biology Technology:United States Strategies in the Immunoprotein Diagnostic Testing Market Report 2015 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 3Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Freezer Space Can Now Be Configured Your Way with New Modular Freezer Racks 2
... Health , Inc. (Nasdaq: GHDX ) today announced that ... November 8 at 4:30 p.m. Eastern Time to discuss its third ... release of the third quarter financial results after market close. ... access the live conference call on November 8 at 4:30 p.m. ...
... Verenium Corporation (Nasdaq: VRNM ), a ... solutions, today announced that it has renewed and extended ... global provider of heat transfer, separation and fluid handling ... Laval signed an agreement to jointly market enzymatic degumming ...
... the physiocrine therapeutics company, today announced a $23 ... Associates.  Domain joins existing venture investors Alta Partners, ... in the financing.  Proceeds will be used to ... advance physiocrine drug candidates into clinical trials.  Physiocrines ...
Cached Biology Technology:Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010 2Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 2Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 3Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement 4aTyr Pharma Secures $23M Financing From Top Tier Venture Investor 2
(Date:5/27/2015)...   Codonics (, a global ... documentation solutions and Omnicell  (, a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
(Date:5/25/2015)... May 25, 2015  Australia,s market for wearable technologies ... 2014 saw the advent of several trials and prototypes. ... 2015 is expected to ignite interest in wearables as ... Australia . This in turn will spur ... drive new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... May 22, 2015 According to ... Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), ... and Utilities, Consumer and Home) - Global Forecast to ... from $2.77 Billion in 2015 to $6.19 Billion by ... Browse 79 market data Tables and   43 Figures ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
... documents dating back 3,500 years say they have found ... ancient Egypt and not with Hippocrates and the Greeks. ... Biomedical Egyptology at The University of Manchester discovered the ... before Hippocrates was born. , "Classical scholars have ...
... and Gail Williams and Stockholm University's Professor Robin Room examined ... and 2002. , Their results were published in the ... Review. , The men were categorised according to ... is a marker for lower socio-economic status (SES). ...
... Investigator, and Nancy Bae, Ph.D., Postdoctoral Research Associate ... offering insight into the way cells protect chromosome ... tomorrow's issue of Molecular Cell, their paper entitled ... Human Telomeric DNA Ends" employed a biochemical assay ...
Cached Biology News:Egyptians, not Greeks were true fathers of medicine 2Double the death rate from cirrhosis for 'blue collar' men 2Baumann Lab defines proteins that distinguish chromosome ends from DNA double-strand breaks 2
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Biology Products: